LT2016100ALT2016100ALT2016100ALT2016100ALT 2016100 ALT2016100 ALT 2016100ALT 2016100 ALT2016100 ALT 2016100ALT 2016100 ALT2016100 ALT 2016100ALT 2016100 ALT2016100 ALT 2016100A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uab ProfarmafiledCriticalUab Profarma
Priority to LT2016100ApriorityCriticalpatent/LT6389B/lt
Publication of LT2016100ApublicationCriticalpatent/LT2016100A/lt
Publication of LT6389BpublicationCriticalpatent/LT6389B/lt
Micro-Organisms Or Cultivation Processes Thereof
(AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents
(AREA)
Abstract
Genetiniais metodais sukonstruoti ir išgryninti nauji dimeriniai antikūno fragmentai prieš vaginoliziną, kurie efektyviai neutralizuoja citolizinį vaginolizino poveikį žmogaus ląstelėms ir gali būti naudojami Gardnerella vaginalis sukeltos bakterinės vaginozės profilaktikai ir (arba) gydymui.